DGDA: Use of antibiotics restricted for coronavirus treatment

  28 March 2020

DGDA Director General (DG) Maj Gen Md Mahbubur Rahman said this at a press conference in Dhaka on Monday morning.

At the press conference, Delta Pharma Ltd announced to provide 300,000 necessary medicines (tablets) to treat Covid-19 patients. The medicines include Hydroxychloroquine and Azithromycin.

The director general said 100,000 tablets can be used for 20,000 coronavirus affected patients.

Apart from Delta Pharma, other pharmaceutical companies are also ready to supply medicines, he added

Further reading: Dhaka Tribune
Author(s): Dhaka Tribune
Healthy Patients  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!